Common variable immunodeficiency syndrome associated with epidermodysplasia verruciformis

American Journal of Clinical Dermatology

Volumn 8, Issue 5, 2007, Pages 307-310

  Vu, Jenny ^a,b   Wallace, Genevieve R ^a   Singh, Rajendra ^a   Diwan, Hafeez ^a   Prieto, Victor ^a   Rady, Peter ^a   Tyring, Stephen ^a   Duvic, Madeleine ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; CASE REPORT; COMMON VARIABLE IMMUNODEFICIENCY; EPIDERMODYSPLASIA VERRUCIFORMIS; FAMILY; FEMALE; GENE SEQUENCE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 23; HUMAN PAPILLOMAVIRUS TYPE 8; HUMAN TISSUE; MOLECULAR CLONING; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAMPLE; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS; VIRUS TYPING; WART VIRUS;

EID: 35148857125     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200708050-00006     Document Type: Article

References (24)

1. Resnick RM, Cornelissen MT, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990; 82: 1477-84
2. Berkhout RJ, Tieben LM, Smits HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995; 33: 690-5
3. de Oliveira WR, He Q, Rady PL, et al. HPV typing in Brazilian patients with epidermodysplasia verruciformis: high prevalence of EV-HPV 25. J Cutan Med Surg 2004; 8: 110-5
4. Doorbar J, Sterling JC. The biology of human papillomavirus. In: Sterling JC, Tyring SK, editors. Human papillomaviruses: clinical and scientific advances. New York: Oxford University Press, 2001: 10-23
5. Orth G, Favre M, Majewski S, et al. Epidermodysplasia verruciformis defines a subset of cutaneous human papillomaviruses. J Virol 2001; 75: 4952-3
6. Di Renzo M, Pasqui AL, Auteri A, et al. Common variable immunodeficiency: a review. Clin Exp Med 2004; 3 (4): 211-7
7. Sneller MC. Common variable immunodeficiency. Am J Med Sci 2001; 321 (1): 42-8
8. Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol 2006; 117: 740-6
9. Castigli E, Wilson SA, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005; 37: 829-34
10. Salzer U, Chapel HM, Webster AD, et al. Mutations in TNFRSF13B encoding TCI are associated with common variable immunodeficiency in humans. Nat Genet 2005; 37: 820-8
11. Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol 2002; 138 (5): 649-54
12. Sterling JC. Human papillomaviruses and skin cancer. J Clin Virol 2005; 32 Suppl. 1: S67-71
13. Leigh IM, Buchanan JA, Harwood CA, et al. Role of human papillomaviruses in cutaneous and oral manifestations of immunosuppression. J Acquir Immune Defic Syndr 1999; 21 Suppl. 1: S49-57
14. Harwood CA, McGregor JM, Proby CM, et al. Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol 1999; 52 (4): 249-53
15. Akgul B, Cooke JC, Storey A, et al. HPV-associated skin disease. J Pathol 2006; 208 (2): 165-75
16. Majewski S, Skopinska-Rozewska E, Jablonska S, et al. Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 1986; 15 (5 Pt 1): 966-73
17. Ramoz NL, Rueda A, Bouadjar B, et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002; 32 (4): 579-81
18. Kurima K, Yang Y, Sorber K, et al. Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 2003; 82 (3): 300-8
19. Goldes JA, Filipovich AH, Neudorf SM, et al. Epidermodysplasia verruciformis in a setting of common variable immunodeficiency. Pediatr Dermatol 1984; 2 (2): 136-9
20. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of local immunosurveillance. Am J Med Sci 1992; 304 (3): 174-9
21. Tate G, Suzuki T, Kishimoto K, et al. Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. J Hum Genet 2004; 49: 223-5
22. Sun XK, Chen JF, Xu AE, et al. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin Exp Dermatol 2005; 30 (5): 573-4
23. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995; 131 (11): 1312-8
24. Azzimonti B, Mondini M, De Andrea M, et al. CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis. Arch Dermatol 2005; 141 (10): 1323-5